The Horst-Schmidt-Kliniken in the district of Dotzheim is the largest hospital complex in Wiesbaden founding in 1879, owing to its affiliated institutions and 1,027 beds. In 1982 the new buildings were relocated to the present location.

During the past decade, Dr. Horst-Schmidt-Kliniken conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 8 clinical trials were completed, i.e. on average, 32% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 2 clinical trials were completed. i.e. 15.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dr. Horst-Schmidt-Kliniken" #1 sponsor was "Dr. Horst Schmidt Klinik GmbH" with 8 trials, followed by "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 5 trials sponsored, "AGO Research GmbH" with 4 trials sponsored, "AGO Study Group" with 4 trials sponsored and "Pfizer" with 4 trials sponsored. Other sponsors include 41 different institutions and companies that sponsored additional 43 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dr. Horst-Schmidt-Kliniken" #1 collaborator was "Hoffmann-La Roche" with 4 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 3 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 2 trials as a collaborator, "Belgian Gynaecological Oncology Group" with 2 trials as a collaborator and "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials as a collaborator. Other collaborators include 57 different institutions and companies that were collaborators in the rest 64 trials.

According to Clinical.Site data, the most researched conditions in "Dr. Horst-Schmidt-Kliniken" are "Ovarian Cancer" (10 trials), "Lymphoma" (8 trials), "Adenoma" (5 trials), "Fallopian Tube Cancer" (5 trials) and "Breast Cancer" (4 trials). Many other conditions were trialed in "Dr. Horst-Schmidt-Kliniken" in a lesser frequency.

Most popular intervention types in "Dr. Horst-Schmidt-Kliniken" are "Drug" (50 trials), "Biological" (11 trials), "Device" (10 trials), "Radiation" (10 trials) and "Procedure" (9 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (9 trials), "vincristine sulfate" (8 trials), "doxorubicin hydrochloride" (7 trials), "radiation therapy" (7 trials) and "prednisone" (6 trials). Other intervention names were less common.

The vast majority of trials in "Dr. Horst-Schmidt-Kliniken" are 52 trials for "All" genders and 19 trials for "Female" genders.

Currently, there are NaN active trials in "Dr. Horst-Schmidt-Kliniken". undefined are not yet recruiting, 11 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 41 completed trials in Dr. Horst-Schmidt-Kliniken, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Dr. Horst-Schmidt-Kliniken, 0 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 16 trials that are defined as “Not Applicable".

Dr. Horst-Schmidt-Kliniken has several departments that took part in Clinical trials: "HELIOS Dr. Horst Schmidt Kliniken Wiesbaden; Klinik für Gynäkologie und gynäkologische Onkologie" - 7 trials